The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...

A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...

(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...

Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...

Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.

A groundbreaking international trial, Optima, reveals a genomic test, Prosigna, can identify breast cancer patients unlikely ...